Junseong Park
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling.
Journal: Experimental & molecular medicine
Published: March 22, 2026
NF-κB-active tumors with matrix CAFs and suppressive immunity as key resistance mechanisms to chemoradiation in rectal cancer.
Journal: Experimental & molecular medicine
Published: March 12, 2026
Large Language Model Assistant for Emergency Department Discharge Documentation.
Journal: JAMA network open
Published: October 21, 2025
Correction: Intravesical instillation-based mTOR-STAT3 dual targeting for bladder cancer treatment.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 17, 2025
Tumor microenvironment-preserving gliosarcoma organoids as an in vitro preclinical platform: a comparative analysis with glioblastoma models.
Journal: Journal of translational medicine
Published: May 31, 2025
Single-Cell RNA Sequencing of Baseline Immune Profiles After Third Vaccination Associated with Subsequent SARS-CoV-2 Infection in Naïve Individuals.
Journal: International journal of molecular sciences
Published: March 10, 2025
Comparison of the biological characteristics of glioblastoma tumorspheres obtained from fresh and cryopreserved glioblastoma tissues.
Journal: Journal of neuro-oncology
Published: February 05, 2025
Urban density and depression during COVID-19 in Seoul: Moderating effects of social participation.
Journal: PloS one
Published: January 12, 2025
Arcyriaflavin A, a cyclin D1/CDK4 inhibitor, suppresses tumor growth, migration, and invasion of metastatic melanoma cells.
Journal: Cancer cell international
Published: October 04, 2024
N-phenylmaleimide induces bioenergetic switch and suppresses tumor growth in glioblastoma tumorspheres by inhibiting SLC25A11.
Journal: Cancer cell international
Published: September 06, 2024
Last Updated: 09/26/2026